Cite
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
MLA
Kelbæk, Henning, et al. “Deferred versus Conventional Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction (DANAMI 3-DEFER): An Open-Label, Randomised Controlled Trial.” Lancet, vol. 387, no. 10034, May 2016, pp. 2199–206. EBSCOhost, https://doi.org/10.1016/S0140-6736(16)30072-1.
APA
Kelbæk, H., Høfsten, D. E., Køber, L., Helqvist, S., Kløvgaard, L., Holmvang, L., Jørgensen, E., Pedersen, F., Saunamäki, K., De Backer, O., Bang, L. E., Kofoed, K. F., Lønborg, J., Ahtarovski, K., Vejlstrup, N., Bøtker, H. E., Terkelsen, C. J., Christiansen, E. H., Ravkilde, J., & Tilsted, H.-H. (2016). Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet, 387(10034), 2199–2206. https://doi.org/10.1016/S0140-6736(16)30072-1
Chicago
Kelbæk, Henning, Dan Eik Høfsten, Lars Køber, Steffen Helqvist, Lene Kløvgaard, Lene Holmvang, Erik Jørgensen, et al. 2016. “Deferred versus Conventional Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction (DANAMI 3-DEFER): An Open-Label, Randomised Controlled Trial.” Lancet 387 (10034): 2199–2206. doi:10.1016/S0140-6736(16)30072-1.